Dr. Martens plc
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Dr. Martens plc (DRMTY) - Net Assets
Latest net assets as of September 2025: $443.05 Million USD
Based on the latest financial reports, Dr. Martens plc (DRMTY) has net assets worth $443.05 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.17 Billion) and total liabilities ($721.99 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $443.05 Million |
| % of Total Assets | 38.03% |
| Annual Growth Rate | 64.75% |
| 5-Year Change | 143.13% |
| 10-Year Change | N/A |
| Growth Volatility | 530.82 |
Dr. Martens plc - Net Assets Trend (2014–2025)
This chart illustrates how Dr. Martens plc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Dr. Martens plc (2014–2025)
The table below shows the annual net assets of Dr. Martens plc from 2014 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | $366.40 Million | -0.49% |
| 2024-03-31 | $368.20 Million | -8.91% |
| 2023-03-31 | $404.20 Million | +23.16% |
| 2022-03-31 | $328.20 Million | +117.78% |
| 2021-03-31 | $150.70 Million | +113.76% |
| 2020-03-31 | $70.50 Million | +939.29% |
| 2019-03-31 | $-8.40 Million | +71.43% |
| 2018-03-31 | $-29.40 Million | -63.33% |
| 2017-03-31 | $-18.00 Million | -63.64% |
| 2016-03-31 | $-11.00 Million | -1475.00% |
| 2015-03-31 | $800.00K | -46.98% |
| 2014-03-31 | $1.51 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Dr. Martens plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 175685000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $1.75 Billion | 477.37% |
| Common Stock | $9.60 Million | 2.62% |
| Total Equity | $366.40 Million | 100.00% |
Dr. Martens plc Competitors by Market Cap
The table below lists competitors of Dr. Martens plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Cognyte Software Ltd
NASDAQ:CGNT
|
$405.37 Million |
|
Mah Sing Group Bhd
KLSE:8583
|
$405.47 Million |
|
Shanghai SK Petroleum & Chemical Equipment Corp Ltd
SHE:002278
|
$405.53 Million |
|
ANGELALIGN TECHNOLOGY INC
PINK:AGLFF
|
$405.57 Million |
|
Healthcare Trust Inc PR
NASDAQ:HTIA
|
$405.24 Million |
|
ARROW FINL CORP. DL 1
F:BQE
|
$405.18 Million |
|
Suzhou Huaya Intelligence Technology Co Ltd
SHE:003043
|
$405.16 Million |
|
Zhejiang Xinneng Photovoltaic Technology Co Ltd
SHG:603105
|
$405.00 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Dr. Martens plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 368,200,000 to 366,400,000, a change of -1,800,000 (-0.5%).
- Net income of 4,500,000 contributed positively to equity growth.
- Dividend payments of 9,500,000 reduced retained earnings.
- Other comprehensive income decreased equity by 11,000,000.
- Other factors increased equity by 14,200,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $4.50 Million | +1.23% |
| Dividends Paid | $9.50 Million | -2.59% |
| Other Comprehensive Income | $-11.00 Million | -3.0% |
| Other Changes | $14.20 Million | +3.88% |
| Total Change | $- | -0.49% |
Book Value vs Market Value Analysis
This analysis compares Dr. Martens plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.04x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 250.86x to 1.04x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-03-31 | $0.00 | $0.78 | x |
| 2015-03-31 | $0.00 | $0.78 | x |
| 2016-03-31 | $-0.02 | $0.78 | x |
| 2017-03-31 | $-0.04 | $0.78 | x |
| 2018-03-31 | $-0.12 | $0.78 | x |
| 2019-03-31 | $-0.03 | $0.78 | x |
| 2020-03-31 | $0.40 | $0.78 | x |
| 2021-03-31 | $0.30 | $0.78 | x |
| 2022-03-31 | $0.65 | $0.78 | x |
| 2023-03-31 | $0.81 | $0.78 | x |
| 2024-03-31 | $0.75 | $0.78 | x |
| 2025-03-31 | $0.75 | $0.78 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Dr. Martens plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.23%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.57%
- • Asset Turnover: 0.89x
- • Equity Multiplier: 2.43x
- Recent ROE (1.23%) is above the historical average (-155.06%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -2122.02% | -19.52% | 0.48x | 226.23x | $-32.15 Million |
| 2015 | 25.00% | 0.08% | 0.65x | 454.00x | $120.00K |
| 2016 | 0.00% | -5.16% | 0.62x | 0.00x | $-10.90 Million |
| 2017 | 0.00% | -3.89% | 0.69x | 0.00x | $-9.50 Million |
| 2018 | 0.00% | -1.64% | 0.78x | 0.00x | $-2.76 Million |
| 2019 | 0.00% | 3.79% | 1.01x | 0.00x | $18.04 Million |
| 2020 | 106.10% | 11.13% | 1.02x | 9.31x | $67.75 Million |
| 2021 | 23.03% | 4.49% | 1.18x | 4.33x | $19.63 Million |
| 2022 | 55.21% | 19.95% | 1.06x | 2.62x | $148.38 Million |
| 2023 | 31.89% | 12.89% | 1.01x | 2.46x | $88.48 Million |
| 2024 | 18.79% | 7.89% | 0.92x | 2.59x | $32.38 Million |
| 2025 | 1.23% | 0.57% | 0.89x | 2.43x | $-32.14 Million |
Industry Comparison
This section compares Dr. Martens plc's net assets metrics with peer companies in the Footwear & Accessories industry.
Industry Context
- Industry: Footwear & Accessories
- Average net assets among peers: $14,906,776,702
- Average return on equity (ROE) among peers: 15.50%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Dr. Martens plc (DRMTY) | $443.05 Million | -2122.02% | 1.63x | $405.34 Million |
| Adidas AG (ADDDF) | $7.06 Billion | 28.00% | 1.93x | $29.25 Billion |
| American Rebel Holdings Inc (AREB) | $-5.01 Million | 0.00% | 0.00x | $820.83K |
| American Rebel Holdings Inc. Warrants (AREBW) | $-646.27K | 0.00% | 0.00x | $10.11K |
| ASICS Corporation (ASCCF) | $138.08 Billion | 9.97% | 0.77x | $14.51 Billion |
| Birkenstock Holding plc (BIRK) | $2.40 Billion | 3.13% | 1.01x | $2.66 Billion |
| Boss Holdings Inc (BSHI) | $18.59 Million | 4.22% | 0.25x | $144.31K |
| Eatware Inc (CHSH) | $3.45 Million | 18.93% | 0.33x | $0.97 |
| Crocs Inc (CROX) | $817.93 Million | 66.04% | 4.50x | $3.98 Billion |
| Designer Brands Inc (DBI) | $640.76 Million | 16.80% | 0.57x | $153.96 Million |
| Deckers Outdoor Corporation (DECK) | $57.10 Million | 7.88% | 0.31x | $14.69 Billion |